| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.05B | 1.51B | 1.05B | 894.40M | 755.41M |
| Gross Profit | 434.74M | 316.35M | 217.29M | 177.03M | 121.92M |
| EBITDA | 169.22M | 62.95M | 104.51M | -30.01M | 2.71M |
| Net Income | 61.71M | 15.74M | 21.80M | 14.99M | -24.96M |
Balance Sheet | |||||
| Total Assets | 883.89M | 814.66M | 691.55M | 602.07M | 746.97M |
| Cash, Cash Equivalents and Short-Term Investments | 186.18M | 188.54M | 185.37M | 137.28M | 172.52M |
| Total Debt | 23.72M | 128.02M | 127.66M | 87.46M | 93.62M |
| Total Liabilities | 587.48M | 592.34M | 432.44M | 354.04M | 387.61M |
| Stockholders Equity | 289.34M | 215.25M | 250.09M | 235.40M | 336.80M |
Cash Flow | |||||
| Free Cash Flow | 159.95M | 219.29M | 30.08M | 17.58M | -12.84M |
| Operating Cash Flow | 214.29M | 284.59M | 108.00M | 97.89M | 42.48M |
| Investing Cash Flow | -84.64M | -81.17M | -75.47M | -99.71M | 18.18M |
| Financing Cash Flow | -180.59M | -185.53M | 5.29M | -54.23M | 61.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$22.32B | 8.94 | 24.66% | ― | 35.67% | 301.55% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | HK$2.61B | 15.82 | 9.22% | 0.94% | 23.33% | 50.23% | |
57 Neutral | HK$2.66B | 19.49 | 4.13% | ― | 63.98% | 2262.50% | |
55 Neutral | HK$636.00M | -13.87 | -5.86% | 1.90% | 6.14% | -122.97% | |
43 Neutral | HK$1.96B | -7.09 | -23.25% | ― | 106.79% | -93.86% | |
40 Underperform | HK$461.41M | -147.00 | -5.43% | ― | 319.04% | 88.85% |